Cliff Saffron, principal, KPMG Pharmaceutical Advisory Services
Dvorit Samid, vice president of medical affairs, Allos Therapeutics
David Sans, managing director, life sciences capital markets, Sunrise
Cathy Santus, clinical supplies program manager, ImClone Systems, a subsidiary of Eli Lilly
Michael Schick, vice president of marketing, Allos Therapeutics
Amy Schinagl, specialist II, global process optimization, ImClone Systems, a subsidiary of Eli Lilly
Rob Schinagl, associate vice president, product champion, ImClone Systems, a subsidiary of Eli Lilly
Michael Schneider, director of internal audits, Ikaria
Tadd Siano, senior supervisor, Pfizer
David Sidransky, professor, Johns Hopkins University
Jeffrey Skulsky, vice president of information technology, Regeneron Pharmaceuticals
Arvind Srivastava, director, ImClone Systems, a subsidiary of Eli Lilly
Ana Stancic, senior vice president and chief financial officer, M2Gen
Steve Steckel, independent pharmaceuticals professional
Kim Stryker, medical writing quality control auditor, ImClone Systems, a subsidiary of Eli Lilly
Shanmuuga Sundaram, principal scientist, ImClone Systems, a subsidiary of Eli Lilly
Doug Swan, vice president of commercial operations, Biodesix
Crystal Szobonya, associate director of portfolio management, ImClone Systems, a subsidiary of Eli Lilly
Tim Talomie, associate vice president, global new products planning/strategic marketing, ImClone Systems, a subsidiary of Eli Lilly
Joe Tarnowski, senior vice president, biologics manufacturing and process development, Bristol-Myers Squibb
Michelle Tenerelli, executive director, project leadership, Celgene
Rian Thornton, senior clinical research coordinator, Children’s Hospital of Atlanta
M. Carolina Tuma, consultant, Recepta Biopharma
Adair Turner, regulatory submissions manager
Troy Unfried, consultant, sales learning & development, Eli Lilly
Erika Varriale, associate director, ethics and compliance, ImClone Systems, a subsidiary of Eli Lilly
Harlan Waksal, owner, Waksal Consulting
Sam Waksal, chairman and CEO, Kadmon Pharmaceuticals
Terri Washington, senior director, Allos Therapeutics
